Who founded Invoke Bio?

Invoke Bio was founded by TJ Sears, Luke Forsthoefel.

Who are Invoke Bio's investors?

Invoke Bio's investors include HCVC.

Invoke Bio

1 known investors

Find your way into Invoke Bio

344 people in our graph share verified history with the Invoke Bio team — schools, employers, funds. One of them is your warm intro.

Elliot Geidtunlockedknows Luke Forsthoefel · together at Stanford University Graduate School of Business (overlapped)

×3knows the team · via Stanford University Graduate School of Business

×2knows the team · via BMO Capital Markets

×6knows the team · via Wesleyan University

Invoke develops personalized cancer treatments using computational biology to predict neoantigens with greater accuracy by modeling individual tumor evolution and immune dynamics. The company serves cancer patients through neoantigen prediction models designed for treatment personalization.

AI & Machine Learning Biotech Digital Health Healthtech

Founders & leadership

TJ SearsinCo-Founder & Chief Executive Officer

Luke Forsthoefel inCo-Founder & Chief Business OfficerLuke Forsthoefel is co-founder and chief business officer at Invoke Bio, which develops personalized cancer treatments using neoantigen prediction models. He previously worked in strategy consulting for early-stage and multinational biopharma companies and in investment banking for technology companies, where he focused on commercialization strategy and product launches.

Investors · 1

HCVCParis · $100K – $1M

Frequently asked questions

What does Invoke Bio do?: Invoke develops personalized cancer treatments using computational biology to predict neoantigens with greater accuracy by modeling individual tumor evolution and immune dynamics. The company serves cancer patients through neoantigen prediction models designed for treatment personalization.
Who founded Invoke Bio?: Invoke Bio was founded by TJ Sears, Luke Forsthoefel.
Who are Invoke Bio's investors?: Invoke Bio's investors include HCVC.